UBE2C and breast carcinoma: This finding suggests that although UBE2C expression correlates with worse prognosis of early HR+/HER2– breast cancer in this study, since most highly malignant breast cancer cases also show high UBE2C expression, it implies that the expression does not hold a prognostic value.